Altria's Discount Strategy: Is Basic Brand a Smart Move for It? — Neutral
MO Zacks Investment Research — January 12, 2026MO shifts its cigarette mix toward lower-priced options as consumers become more price-conscious, helping cushion volume pressure in a challenging market.
Amphenol (APH) Crossed Above the 50-Day Moving Average: What That Means for Investors — Positive
APH Zacks Investment Research — January 12, 2026Amphenol (APH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, APH broke out above the 50-day moving average, suggesting a short-term bullish trend.
Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch — Positive
CBRE Zacks Investment Research — January 12, 2026Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Brokers Suggest Investing in APTIV HLDS LTD (APTV): Read This Before Placing a Bet — Negative
APTV Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is It Worth Investing in SkyWater Technology (SKYT) Based on Wall Street's Bullish Views? — Neutral
SKYT Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wall Street Bulls Look Optimistic About Clear Secure (YOU): Should You Buy? — Positive
YOU Zacks Investment Research — January 12, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True? — Neutral
CRSP Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views? — Neutral
GTN Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It? — Positive
CLSK Zacks Investment Research — January 12, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Wall Street Analysts See Toyota Motor (TM) as a Buy: Should You Invest? — Neutral
TM Zacks Investment Research — January 12, 2026When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Wall Street Analysts See Coupang (CPNG) as a Buy: Should You Invest? — Negative
CPNG Zacks Investment Research — January 12, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy? — Positive
MRK Zacks Investment Research — January 12, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic? — Positive
PG Zacks Investment Research — January 12, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Lam Research has displayed impressive bullish momentum, with over a dozen rallies surpassing 30% within two months, especially in years such as 2010 and 2025. Four of these increases exceeded 50%, highlighting the stock's capacity for swift gains.
Applied Digital jumped nearly 18% on January 9, 2026, closing at $37.68, following the announcement of a remarkable 250% year-over-year revenue growth in its fiscal Q2 earnings. This movement was marked by aggressive purchasing and considerable volume, indicating a substantial change in investor sentiment.
Google parent company Alphabet has become the fourth member of the $4 trillion club Alphabet's stock climbed to record highs after investment firms said they see more upside for Google in 2026.
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference — Neutral
BBIO GlobeNewsWire — January 12, 2026- Preliminary unaudited Q4 and Full Year 2025 net Attruby ® product revenue of $146.0 million and $362.4 million, respectively
Innospec Schedules Fourth Quarter 2025 Earnings Release and Conference Call — Neutral
IOSP GlobeNewsWire — January 12, 2026ENGLEWOOD, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release fourth quarter 2025 earnings results on Tuesday, February 17, 2026, after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, February 18, 2026, at 9:00 a.m. ET.
Portnoy Law Firm Announces Class Action on Behalf of Integer Holdings Corporation Investors — Neutral
ITGR GlobeNewsWire — January 12, 2026LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Integer Holdings Corporation, (“Integer” or the "Company") (NYSE: ITGR) investors of a class action on behalf of investors that bought securities between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). Integer investors have until February 9, 2026 to file a lead plaintiff motion.
Nvidia Partners With Eli Lilly on AI Drug Laboratory — Positive
LLY NVDA Bloomberg Markets and Finance — January 12, 2026Nvidia plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry. Jessica Nix has more on "Bloomberg Open Interest.